Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Dainippon and Questcor modify antibacterial research agreement

Feb. 9, 2000

Antiinfluenza sialic acid derivatives emerge from R&D at RIKEN

Feb. 8, 2000

Levaquin as the first antimicrobial for CAP caused by resistant S. pneumoniae

Feb. 7, 2000

News from ICMASKO 5: Pliva describes new azalides

Feb. 4, 2000

InterMune begins phase II trial of Actimmune in cryptococcal meningitis

Feb. 4, 2000

Telithromycin featured in multiple presentations at ICMASKO 5

Feb. 4, 2000

Sporanox Injection now available for treatment of serious fungal infections

Feb. 4, 2000

Pliva presents new azithromycin derivatives at ICMASKO 5

Feb. 3, 2000

BMS informs of first launch for new quinolone

Feb. 3, 2000

Potent, broad-spectrum cephalosporins in development at Roche

Feb. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...